Expressions and prognostic value of EGFR, COX-2, Ki-67, and p53 in gastrointestinal stromal tumors
JIANG Jing,JIN Mei-shan,MA Hong-xi,SUO Jian,WANG Yin-ping,HE Liang,CAO Xue-yuan
DOI: https://doi.org/10.3877/cma.j.issn.1674-3946.2013.02.034
2013-01-01
Abstract:Objective To detect the expression of Ki-67,p53,EGFR,COX-2 in GIST and to investigate their prognostic value.Methods An immunohistochemical technique(SP) was used to detect the expression of Ki-67,p53,EGFR,and COX-2 in the specimens of 96 patients with GIST.Clinical multivariate retrospective analysis was used to evaluate the correlation between expression of these proteins,tumor morphologic parameters,modified National Institutes of Health(NIH) consensus criteria and clinical outcomes.Results The Ki-67 expression in GISTs was significantly associated with the size of tumors,mitotic rate and the risk of malignancy(χ2=13.34,P0.001;χ2=20.31,P0.001;χ2=18.81,P0.001 respectively).The p53 expression was also significantly correlated with mitotic rate and the risk of malignancy(χ2=4.91,P=0.03;χ2=5.80;P=0.02 respectively).Over-expression of Ki-67 was strongly correlated with poor survival(χ2=10.44,P=0.006),but no correlation was found between the expression of p53,EGFR,or COX-2 and survival(χ2=4.744,χ2=1.271,χ2=1.679;P0.05).Multivariate analysis further demonstrated that Ki-67 expression(RR=15.78,95%CI:4.25-59.37) could be used as an independent prognostic factor for GIST patients.The adjuvant imatinib therapy could improve clinical outcomes in the patients with high-intermediate risk of recurrences after tumor resection(Median survival time:52 vs.37 months,χ2 =7.618,P=0.006).Conclusion Expression of Ki-67 can be used in the prognosis prediction of GIST patients independently.